Captrust Financial Advisors Has $123.16 Million Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Captrust Financial Advisors cut its stake in HCA Healthcare, Inc. (NYSE:HCA) by 0.8% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 303,028 shares of the company’s stock after selling 2,592 shares during the period. Captrust Financial Advisors owned approximately 0.12% of HCA Healthcare worth $123,160,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of HCA. Bangor Savings Bank boosted its holdings in HCA Healthcare by 112.5% in the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after purchasing an additional 45 shares during the period. MFA Wealth Advisors LLC bought a new stake in HCA Healthcare in the 2nd quarter valued at $27,000. Unique Wealth Strategies LLC bought a new position in shares of HCA Healthcare during the 2nd quarter worth about $28,000. GPS Wealth Strategies Group LLC boosted its position in shares of HCA Healthcare by 284.0% during the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after acquiring an additional 71 shares in the last quarter. Finally, Benjamin F. Edwards & Company Inc. acquired a new stake in shares of HCA Healthcare during the 2nd quarter valued at about $33,000. 62.73% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several analysts have recently weighed in on the stock. UBS Group lifted their target price on shares of HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a research report on Wednesday, August 14th. Raymond James lowered shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday, November 22nd. Cantor Fitzgerald restated an “overweight” rating and issued a $392.00 price target on shares of HCA Healthcare in a research report on Tuesday, October 1st. Barclays reduced their price target on shares of HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating on the stock in a research report on Friday, November 8th. Finally, TD Cowen reduced their price target on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a research report on Monday, October 28th. One analyst has rated the stock with a sell rating, five have assigned a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $380.29.

Insider Activity

In related news, EVP Michael S. Cuffe sold 8,358 shares of the firm’s stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the sale, the executive vice president now owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. This trade represents a 21.97 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, SVP Phillip G. Billington sold 3,897 shares of the firm’s stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the sale, the senior vice president now directly owns 52,702 shares in the company, valued at $18,445,700. The trade was a 6.89 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 15,155 shares of company stock valued at $5,608,990 in the last 90 days. 1.60% of the stock is owned by company insiders.

HCA Healthcare Trading Down 1.1 %

Shares of NYSE HCA opened at $325.47 on Friday. The company’s 50 day simple moving average is $373.42 and its 200 day simple moving average is $358.28. The firm has a market capitalization of $82.44 billion, a P/E ratio of 14.61, a P/E/G ratio of 1.25 and a beta of 1.68. HCA Healthcare, Inc. has a fifty-two week low of $245.84 and a fifty-two week high of $417.14. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be paid a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.81%. The ex-dividend date is Friday, December 13th. HCA Healthcare’s dividend payout ratio (DPR) is currently 11.85%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.